These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 604127)

  • 1. Properties of A/Victoria/3/75 recombinants: development of an attenuated strain RIT 4050.
    Lobmann M; Delem A; Jovanović D
    Dev Biol Stand; 1977 Jun 1-3; 39():43-6. PubMed ID: 604127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live influenza vaccine in patients with chronic bronchopulmonary diseases. A multicenter study with two consecutive vaccinal strains.
    Bartsch P; Dierckx JP; Frans A; Gillard C; Jovanović D; Stanescu D
    Dev Biol Stand; 1977 Jun 1-3; 39():113-21. PubMed ID: 604093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of live recombinant influenza vaccine.
    Stealey VM; McCahon D; Freestone DS
    Dev Biol Stand; 1976; 33():191-6. PubMed ID: 955267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers.
    Hrabar A; Vodopija I; André FE; Mitchell JR; Maassab HF; Hennessy AV; Davenport FM
    Dev Biol Stand; 1977 Jun 1-3; 39():53-60. PubMed ID: 342317
    [No Abstract]   [Full Text] [Related]  

  • 5. A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination.
    White WG; Freestone DS; Bowker CH; Barnes GM; Letley E; Ferris RD
    Dev Biol Stand; 1976; 33():202-6. PubMed ID: 782970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults.
    Warshauer DM; Minor TE; Inhorn SL; Reed CE; Dick EC
    Dev Biol Stand; 1976; 33():184-90. PubMed ID: 782967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of live attenuated influenza vaccine ts-1(E) in man.
    Gwaltney JM
    Dev Biol Stand; 1976; 33():178-83. PubMed ID: 782966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditions for production of thermosensitive attenuated influenza virus recombinants.
    Polezhaev FI; Garmashova LM; Polyakov YM; Golubev DB; Aleksandrova GI
    Acta Virol; 1978 Jul; 22(4):263-9. PubMed ID: 29464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies with live attenuated influenza vaccines.
    Douglas RG; Betts RF
    Am J Clin Pathol; 1978 Jul; 70(1 Suppl):153-8. PubMed ID: 685888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of respiratory function in volunteers given live influenza virus vaccine.
    Nicholson KG; Lawford CV; Tyrrell DA
    Dev Biol Stand; 1977 Jun 1-3; 39():129-34. PubMed ID: 604095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical control, study of viral shedding and evaluation of circulating and local antibody response after administration of live and attenuated "Alice" strain influenza vaccine].
    Bergamini F; Profeta ML; Ferroni P; Zanetti AR
    Boll Ist Sieroter Milan; 1976 Mar; 55(71):1-12. PubMed ID: 1021151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
    Belshe RB; Gruber WC; Mendelman PM; Mehta HB; Mahmood K; Reisinger K; Treanor J; Zangwill K; Hayden FG; Bernstein DI; Kotloff K; King J; Piedra PA; Block SL; Yan L; Wolff M
    J Infect Dis; 2000 Mar; 181(3):1133-7. PubMed ID: 10720541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further researches on live influenza virus vaccines.
    De Barbieri A; Crovari P; Cuneo-Crovari P; Giacometti G
    Dev Biol Stand; 1977 Jun 1-3; 39():73-6. PubMed ID: 604136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live attenuated influenza vaccine in children.
    Ambrose CS; Walker RE; Connor EM
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of an attenuated influenza A (H3N2) strain "KO-1" by recombination with A/Okuda/57 (H2N2) followed by selection of inhibitor-resistant virus.
    Yamada A; Okuno Y; Takahashi M; Nakajima K
    Biken J; 1980 Mar; 23(1):25-32. PubMed ID: 7437002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on influenza-virus virulence in recombinants between epidemic and vaccine strains.
    Zazimko LA; Vakin VS; Sklyanskaya EI; Zhdanov VM
    Acta Virol; 1987 Sep; 31(5):387-96. PubMed ID: 2891277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of influenza A/Victoria/3/75-ts-1 [E] recombinant viruses for attenuation and immunogenicity in adult seronegative volunteers.
    Murphy BR; Markoff LJ; Chanock RM; Douglas RG; Betts RF; Cate TR; Couch RB
    Dev Biol Stand; 1977 Jun 1-3; 39():47-52. PubMed ID: 604132
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials with intranasally administered WRL 105 strain live influenza vaccine in volunteers.
    Freestone DS
    Dev Biol Stand; 1976; 33():207-12. PubMed ID: 782971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.